Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer

Published:2020-09-15 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Peng Muyun,Huang Qi,Yin Wei,Tan Sichuang,Chen Chen,Liu Wenliang,Tang Jingqun,Wang Xiang,Zhang Bingyu,Zou Min,Li Jina,Su Wenhui,Wang Lientu,Chin Lihan,Yu Fenglei

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference25 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;Bray;CA Cancer J Clin.,2018

2. Cancer statistics, 2019.;Siegel;CA Cancer J Clin.,2019

3. Clinical outcomes of microscopic residual disease after bronchial sleeve resection for non-small cell lung cancer.;Hong;J Thoracic Cardiovas Surgery.,2020

4. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.;Murtaza;Nature.,2013

5. Analysis of circulating tumor DNA to monitor metastatic breast cancer.;Dawson;New Engl J Med.,2013

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer;Trends in Cancer;2024-07

2. Liquid biopsy for monitoring minimal residual disease in localized and locally-advanced non-small cell lung cancer after radical-intent treatment;The Journal of Liquid Biopsy;2024-06

3. Circulating tumour DNA-Based molecular residual disease detection in resectable cancers: a systematic review and meta-analysis;eBioMedicine;2024-05

4. Personalized, tumor‐informed, circulating tumor DNA assay for detecting minimal residual disease in non‐small cell lung cancer patients receiving curative treatments;Thoracic Cancer;2024-04

5. Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay;International Journal of Clinical Oncology;2024-03-29